Skip to content

BRASKEM SA

BAK · XNYS

CIK 1071438fmd_06BKZV7JEZW6ZMJZQ21Y8TA44XManufacturing · Industrial Organic ChemicalsTemplate: Standard

Coverage: Jan 01, 2015 to Dec 31, 2025, 13 periods

Income Statement · Annual · Millions · BRL
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues47,66449,26158,00052,32458,543105,62596,51970,56977,41170,717
Cost of revenue34,98636,17746,57745,87947,33173,56885,16167,54871,41469,161
Gross profit12,67813,08311,4236,44411,21232,05711,3583,0215,9971,556
Research and development162167219248251297374383463460
Selling, general and administrative(2,851)3,0613,615(4,262)(4,077)(4,883)(5,285)4,3884,6304,682
Operating income5,9519,2078,280154(72)26,0444,272(2,792)(1,079)(1,807)
Interest expense3,5713,7473,0083,8834,9134,9035,0665,5896,8536,802
Income before taxes(140)5,2653,605(4,603)(9,684)17,96147(6,192)(17,733)(2,845)
Income tax expense6161,358737(1,963)(2,668)3,999868(1,302)(5,681)8,116
Net income from continuing operations(756)3,9072,868(2,640)(7,015)13,962(821)(4,890)(12,052)(10,961)
Net income(411)3,8652,828(2,541)(6,692)13,985(336)(4,579)(11,320)(9,880)
BRASKEM SA (BAK) financial statements · FinancialMD